# 2025-02733: Scottsdale Lab Wants to Brew Big Batches of Marijuana

2025-02733, Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-02-18, effective 2025-04-21; PRIA reads it as touching household money (as of 2026-09-24).

- Canonical: https://policyrisk.com/federal-register/2025-02733
- As of: 2026-09-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-02733
- Title: Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 9731
- Published: 2025-02-18
- Effective: 2025-04-21
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-24

## In one line

Scottsdale Lab Wants to Brew Big Batches of Marijuana

## Summary

Scottsdale Research Institute wants to become a big-time maker of marijuana and related substances for research and clinical trials. If you’re a current manufacturer or interested party, you can share your thoughts or ask for a hearing by April 21, 2025. This move helps boost scientific studies but doesn’t change any other drug activities or costs right now.

## Abstract

Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- New bulk manufacturer for Schedule I cannabis: benefit, low. On January 8, 2025, Scottsdale Research Institute applied to be a bulk manufacturer of Marihuana Extract (code 7350), Marihuana (code 7360), and Tetrahydrocannabinols (code 7370), all listed in Schedule I. The company says it will make these substances to support clinical trials and to distribute t…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-02733 on federalregister.gov](https://www.federalregister.gov/documents/2025/02/18/2025-02733/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute)
- [2025-02733 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-02-18/pdf/2025-02733.pdf)

## Related
- [Previous: 2025-02732, Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.](https://policyrisk.com/federal-register/2025-02732)
- [Next: 2025-02737, Importer of Controlled Substances Application: Lonza Tampa, LLC](https://policyrisk.com/federal-register/2025-02737)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-02733 (as of 2026-09-24).
